Avoro Capital Advisors is a fund manager in New York with $6.47 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry
Former names
venBio Select Advisor LLC
SEC CIK
IRS number
271007403
SEC advisor number
801-74391
FINRA CRD number
154091
AUM ?
$8.74 bn
(as of 5 Mar 24)
Accounts
3
(as of 5 Mar 24)
Employees
15
(10 investment advisory or research)
Address
Avoro Capital Advisors
110 GREENE STREET
SUITE 800
NEW YORK
NY 10012
110 GREENE STREET
SUITE 800
NEW YORK
NY 10012
Phone
212-937-4975
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Avoro Capital Advisors LLC | $6.47 bn | |
Avoro Life Sciences Fund LLC | $6.29 bn | Hedge Fund |
Avoro Life Sciences Offshore Fund LTD. | ||
Avoro Ventures Fund L.P. | $178.48 mm | Venture Capital Fund |
Latest filings (excl ownership)
SC 14D9/A
Tender offer solicitation (amended)
17 Nov 21
SC 14D9/A
Tender offer solicitation (amended)
10 Nov 21
SC 14D9
Tender offer solicitation
28 Oct 21
SC14D9C
Written communication relating to third party tender offer
30 Sep 21
UPLOAD
Letter from SEC
26 Oct 17
UPLOAD
Letter from SEC
24 Oct 17
DFAN14A
Additional proxy materials by non-management
2 Mar 17
DFAN14A
Additional proxy materials by non-management
22 Feb 17
CORRESP
Correspondence with SEC
17 Feb 17
DFAN14A
Additional proxy materials by non-management
14 Feb 17
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13G/A
Krystal Biotech, Inc.
14 Feb 24
SC 13G/A
Apellis Pharmaceuticals, Inc.
14 Feb 24
SC 13G/A
AMICUS THERAPEUTICS, INC.
14 Feb 24
SC 13G/A
MADRIGAL PHARMACEUTICALS, INC.
14 Feb 24
SC 13G/A
Mersana Therapeutics, Inc.
14 Feb 24
SC 13G/A
PMV Pharmaceuticals, Inc.
14 Feb 24
SC 13G/A
Ascendis Pharma A/S
14 Feb 24
SC 13G/A
Kymera Therapeutics, Inc.
14 Feb 24
SC 13G/A
Monte Rosa Therapeutics, Inc.
14 Feb 24
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Sep 23 | Avoro Capital Advisors | Put Option (obligation to buy) Common Stock | Sell | Dispose S | Yes | No | 1.0963 | 950 | 1.04 k | 950 |
13 Sep 23 | Avoro Capital Advisors | Put Option (obligation to buy) Common Stock | Sell | Dispose S | Yes | No | 0.9848 | 250 | 246.20 | 250 |
12 Sep 23 | Avoro Capital Advisors | Pre-funded Warrant Common Stock | Buy | Acquire P | Yes | No | 17.1299 | 583,771 | 10.00 mm | 583,771 |
12 Sep 23 | Avoro Capital Advisors | Put Option (obligation to buy) Common Stock | Sell | Dispose S | Yes | No | 0.998 | 300 | 299.40 | 300 |
12 Sep 23 | Avoro Capital Advisors | Put Option (obligation to buy) Common Stock | Sell | Dispose S | Yes | No | 1 | 1,500 | 1.50 k | 1,500 |
15 Jun 23 | Aghazadeh Behzad | Stock Option Common Stock | Grant | Acquire A | No | No | 8.2 | 28,255 | 231.69 k | 28,255 |
26 Jan 23 | Avoro Capital Advisors | Pre-funded Warrant Common Stock | Buy | Acquire P | Yes | No | 6.9999 | 2,142,857 | 15.00 mm | 2,142,857 |